Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas (Q45028998)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Daniela Capello

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Gianluca Gaidano

14

object named as

Gianluca Gaidano

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Maurilio Ponzoni

4

object named as

Maurilio Ponzoni

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

6

object named as

Davide Rossi

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Andrés J M Ferreri

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Stefania Dell'Oro

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Paolo Iuzzolino

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Felice Pasini

7

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Achille Ambrosetti

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Enrico Orvieto

9

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Fabio Ferrarese

10

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Gianluigi Arrigoni

11

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Marco Foppoli

12

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Michele Reni

13

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

126

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

657-664

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

A multicenter study of treatment of primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

CpG island methylation of tumor-related genes in three primary central nervous system lymphomas in immunocompetent patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Intrinsic and acquired resistance to methotrexate in acute leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Reduced folate carrier gene silencing in multiple antifolate-resistant tumor cell lines is due to a simultaneous loss of function of multiple transcription factors but not promoter methylation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Carrier-mediated membrane transport of folates in mammalian cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05109.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2004.05109.X

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45028998&oldid=2245246573"